• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素受体作为配体诱导的同源二聚体与它的反应元件紧密结合。

The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.

作者信息

Kumar V, Chambon P

机构信息

Laboratoire de Génétique Moléculaire, des Eucaryotes du CNRS, Strasbourg, France.

出版信息

Cell. 1988 Oct 7;55(1):145-56. doi: 10.1016/0092-8674(88)90017-7.

DOI:10.1016/0092-8674(88)90017-7
PMID:3167974
Abstract

Extracts containing wild-type or mutant human estrogen receptor (ER) have been used to study the binding of ER to its responsive element (ERE). Estradiol (E2) or the antiestrogen hydroxytamoxifen is required for ER binding as assayed by gel retardation. The DNA binding domain (DBD) encompasses the highly conserved region C. Both intact ER-E2 complexes and ER mutants truncated for the hormone binding domain (HBD) bind as dimers to an ERE. However, an HBD-truncated ER binds less tightly to an ERE than an intact ER-E2 complex. The DBD and HBD contain a constitutive and a stronger ER-induced dimerization function, respectively. Thus, in addition to inducing the activation function associated with the HBD, estrogen plays a crucial role in the formation of stable ER dimers that bind tightly to ERE.

摘要

含有野生型或突变型人雌激素受体(ER)的提取物已被用于研究ER与其反应元件(ERE)的结合。通过凝胶阻滞分析,雌二醇(E2)或抗雌激素羟基他莫昔芬是ER结合所必需的。DNA结合结构域(DBD)包含高度保守的C区域。完整的ER-E2复合物和激素结合结构域(HBD)被截断的ER突变体均以二聚体形式与ERE结合。然而,HBD截断的ER与ERE的结合比完整的ER-E2复合物更松散。DBD和HBD分别包含组成型和更强的ER诱导的二聚化功能。因此,除了诱导与HBD相关的激活功能外,雌激素在形成与ERE紧密结合的稳定ER二聚体中起着关键作用。

相似文献

1
The estrogen receptor binds tightly to its responsive element as a ligand-induced homodimer.雌激素受体作为配体诱导的同源二聚体与它的反应元件紧密结合。
Cell. 1988 Oct 7;55(1):145-56. doi: 10.1016/0092-8674(88)90017-7.
2
Site-directed estrogen receptor antibodies stabilize 4-hydroxytamoxifen ligand, but not estradiol, and indicate ligand-specific differences in the recognition of estrogen response element DNA in vitro.位点特异性雌激素受体抗体可稳定4-羟基他莫昔芬配体,但不能稳定雌二醇,并表明在体外识别雌激素反应元件DNA时存在配体特异性差异。
Steroids. 1996 May;61(5):278-89. doi: 10.1016/0039-128x(95)00219-g.
3
Dissociation of 4-hydroxytamoxifen, but not estradiol or tamoxifen aziridine, from the estrogen receptor as the receptor binds estrogen response element DNA.当雌激素受体与雌激素反应元件DNA结合时,4-羟基他莫昔芬从该受体上解离,但雌二醇或他莫昔芬氮丙啶不会解离。
J Steroid Biochem Mol Biol. 1996 Jan;57(1-2):51-66. doi: 10.1016/0960-0760(95)00246-4.
4
Differential impact of flanking sequences on estradiol- vs 4-hydroxytamoxifen-liganded estrogen receptor binding to estrogen responsive element DNA.侧翼序列对雌二醇与4-羟基他莫昔芬配体化雌激素受体结合雌激素反应元件DNA的差异影响。
J Steroid Biochem Mol Biol. 1993 Dec;46(6):713-30. doi: 10.1016/0960-0760(93)90312-k.
5
Stability of the ligand-estrogen receptor interaction depends on estrogen response element flanking sequences and cellular factors.配体-雌激素受体相互作用的稳定性取决于雌激素反应元件侧翼序列和细胞因子。
J Steroid Biochem Mol Biol. 1996 Dec;59(5-6):413-29. doi: 10.1016/s0960-0760(96)00129-x.
6
Cooperative binding of estrogen receptor to DNA depends on spacing of binding sites, flanking sequence, and ligand.雌激素受体与DNA的协同结合取决于结合位点的间距、侧翼序列和配体。
Biochemistry. 1995 Feb 28;34(8):2511-20. doi: 10.1021/bi00008a015.
7
Allosteric silencing of activating function 1 in the 4-hydroxytamoxifen estrogen receptor complex is induced by substituting glycine for aspartate at amino acid 351.在4-羟基他莫昔芬雌激素受体复合物中,通过将第351位氨基酸的天冬氨酸替换为甘氨酸,可诱导激活功能1的变构沉默。
Cancer Res. 2000 Sep 15;60(18):5097-105.
8
Identification of an estrogen-responsive element in the rat LH beta gene. DNA-estrogen receptor interactions and functional analysis.大鼠促黄体生成素β基因中雌激素反应元件的鉴定。DNA-雌激素受体相互作用及功能分析。
J Biol Chem. 1991 Sep 15;266(26):17084-91.
9
Differential DNA-binding abilities of estrogen receptor occupied with two classes of antiestrogens: studies using human estrogen receptor overexpressed in mammalian cells.两类抗雌激素占据的雌激素受体的差异DNA结合能力:利用在哺乳动物细胞中过表达的人雌激素受体进行的研究
Nucleic Acids Res. 1991 Dec 11;19(23):6595-602. doi: 10.1093/nar/19.23.6595.
10
Human estrogen receptor ligand activity inversion mutants: receptors that interpret antiestrogens as estrogens and estrogens as antiestrogens and discriminate among different antiestrogens.人雌激素受体配体活性反转突变体:将抗雌激素解读为雌激素、将雌激素解读为抗雌激素并区分不同抗雌激素的受体。
Mol Endocrinol. 1996 Mar;10(3):230-42. doi: 10.1210/mend.10.3.8833652.

引用本文的文献

1
Zooming into Gene Activation: Estrogen Receptor α Dimerization and DNA Binding Visualized by High-Speed Atomic Force Microscopy.深入探究基因激活:通过高速原子力显微镜观察雌激素受体α二聚化和DNA结合
ACS Nano. 2025 Apr 29;19(16):15395-15410. doi: 10.1021/acsnano.4c14943. Epub 2025 Apr 18.
2
Synthesis and Anticancer Evaluation of -Alkylated (-Chalcone Derivatives: A Focus on Estrogen Receptor Inhibition.α-烷基化(α-查尔酮衍生物的合成与抗癌评估:聚焦雌激素受体抑制作用
Int J Mol Sci. 2025 Jan 20;26(2):833. doi: 10.3390/ijms26020833.
3
ZNF143 binds DNA and stimulates transcription initiation to activate and repress direct target genes.
锌指蛋白143(ZNF143)与DNA结合并刺激转录起始,以激活和抑制直接靶基因。
Nucleic Acids Res. 2025 Jan 11;53(2). doi: 10.1093/nar/gkae1182.
4
Hydrophobic CPP/HDO conjugates: a new frontier in oligonucleotide-warheaded PROTAC delivery.疏水性细胞穿透肽/疏水寡核苷酸缀合物:寡核苷酸导向的PROTAC递送新前沿。
RSC Med Chem. 2024 Sep 26;15(11):3695-703. doi: 10.1039/d4md00546e.
5
ZNF143 binds DNA and stimulates transcripstion initiation to activate and repress direct target genes.锌指蛋白143(ZNF143)结合DNA并刺激转录起始,以激活和抑制直接靶基因。
bioRxiv. 2024 May 15:2024.05.13.594008. doi: 10.1101/2024.05.13.594008.
6
TRPS1 modulates chromatin accessibility to regulate estrogen receptor alpha (ER) binding and ER target gene expression in luminal breast cancer cells.TRPS1 调节染色质可及性以调节腔乳腺癌细胞中雌激素受体 α (ER) 的结合和 ER 靶基因表达。
PLoS Genet. 2024 Feb 20;20(2):e1011159. doi: 10.1371/journal.pgen.1011159. eCollection 2024 Feb.
7
The effects of peripheral hormone responses to exercise on adult hippocampal neurogenesis.运动对成年海马神经发生的外周激素反应的影响。
Front Endocrinol (Lausanne). 2023 Nov 24;14:1202349. doi: 10.3389/fendo.2023.1202349. eCollection 2023.
8
Nuclear Estrogen Receptors in Prostate Cancer: From Genes to Function.前列腺癌中的核雌激素受体:从基因到功能
Cancers (Basel). 2023 Sep 20;15(18):4653. doi: 10.3390/cancers15184653.
9
Aberrant Cyclin D1 splicing in cancer: from molecular mechanism to therapeutic modulation.癌组织中细胞周期蛋白 D1 剪接异常:从分子机制到治疗调控。
Cell Death Dis. 2023 Apr 6;14(4):244. doi: 10.1038/s41419-023-05763-7.
10
Current Status of Oligonucleotide-Based Protein Degraders.基于寡核苷酸的蛋白质降解剂的现状
Pharmaceutics. 2023 Feb 24;15(3):765. doi: 10.3390/pharmaceutics15030765.